Phenoxodiol Delays Tumor Progression In Late-stage Prostate Cancer

This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.

A new study presented at the International Conference on Molecular Targets and Cancer Therapeutics in Philadelphia, Pennsylvania, shows that phenoxodiol significantly delays tumor progression in men suffering from late-stage hormone refractory prostate cancer.